Colorectal Cancer

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print

Volumn , Issue , 2010, Pages 2191-2238

  Bresalier, Robert S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879624521     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6189-2.00123-2     Document Type: Chapter

References (186)

1. Ahlquist DA., Sargent DJ., Loprinzi CL., et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia Ann Intern Med 149 2008 441-450(Ref 132.)
2. Baron JA., Cole BF., Sandler RS., et al. A randomized trial of aspirin to prevent colorectal adenomas N Engl J Med 348 2003 891-899(Ref 40.)
3. Baron JA., Sandler RS., Bresalier RS., et al. A randomized trial of rofecoxib for the prevention of colorectal adenomas Gastroenterology 131 2006 1674-1682(Ref 47.)
4. Grady WM., Carethers JM Genomic and epigenetic instability in colorectal cancer pathogenesis Gastroenterology 135 2008 1079-1099(Ref 54.)
5. Imperiale TF., Wagner DR., Lin CY., et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings N Engl J Med 343 2000 169-174(Ref 116.)
6. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009 CA Cancer J Clin 59 2009 225-249(Ref 1.)
7. Johnson DJ., Chen M-H., Toledano AY., et al. Accuracy of CT colonography for detection of large adenomas and cancer N Engl J Med 359 2008 1207-1217(Ref 126.)
8. Karpetis CS., Khambata-Ford S., Jonker DK., et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer N Engl J Med 359 2008 1757-1765(Ref 167.)
9. Kelloff GJ., Lippman S., Dannenberg AJ., et al. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward Clin Cancer Res 12 2006 3661-3697(Ref 25.)
10. Levin B., Lieberman DA., Mcfarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology CA Cancer J Clin 58 2008 130-160(Ref 81.)
11. Lieberman DA., Weiss DG., Harford WV., et al. Five year colon surveillance after screening colonoscopy Gastroenterology 133 2007 1077-1085(Ref 135.)
12. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology. Colon Cancer http://www.nccn.org/professionals/physician_gls/f_guidelines.asp 2008 [Internet] [cited 2009 Jun 23] Available at (Ref 156.)
13. Soetikno RM., Kaltenbach T., Rouse RV., et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults JAMA 299 2008 1027-1035(Ref 118.)
14. Steinbach G., Lynch PM., Phillips RK., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 2000 1946-1952(Ref 44.)
15. U.S. Preventative Services Task Force Screening for colorectal cancer: U.S. Preventative Services Task Force recommendation statement Ann Int Med 149 2008 627-637(Ref 96.)
16. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009 CA Cancer J Clin 59 2009 225-249.
17. Ries LA., Wingo PA., Miller DS., et al. The annual report to the nation on the status of cancer, 1973-1977, with a special section on colorectal cancer Cancer 88 2000 2398-2424.
18. Curado MP., Edwards SB., Shin HR., et al. Cancer incidence in five continents vol IX 2007 International Agency for Research on Cancer Lyon.
19. Song S., Byrd JC., Koo JS., Bresalier RS Bile acids induce MUC2 overexpression in human colon carcinoma cells Cancer 103 2005 1606-1614.
20. Glinghammar B., Rafter J Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells Gastroenterology 120 2001 401-410.
21. Dannenberg AJ., Subbaramaiah K Targeting cyclooxygenase-2 in human neoplasia: rationale and promise Cancer Cell 4 2003 431-436.
22. Kaklamani VG., Wasinski KB Sadim M, et al. Variants of the adiponenctin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk JAMA 300 2008 1523-1531.
23. Peters U., Sinha R., Chatterjee N., et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme Lancet 361 2003 1491-1495.
24. Bingham SA., Day NE., Luben R., et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study Lancet 361 2003 1496-1501.
25. Alberts DS., Martinez ME., Roe DJ., et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network N Engl J Med 342 2000 1156-1162.
26. Schatzkin A., Lanza E., Corle D., et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group N Engl J Med 342 2000 1149-1155.
27. Park Y., Hunter DJ., Bergkvist L., et al. Dietary fiber intake and risk of colorectal cancer. A pooled analysis of prospective cohort studies JAMA 294 2005 2849-2857.
28. Holt P., Bresalier RS., Ma CK., et al. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa Cancer 106 2006 287-296.
29. Cho E., Smith Warner SA., Spiegelman D., et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies J Natl Cancer Inst 96 2004 1015-1022.
30. Lamprecht SA., Lipkin M Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms Nature Rev Cancer 3 2003 601-614.
31. Kim KE., Brasitus TA The role of vitamin D in normal and pathologic processes in the colon Curr Opin Gastroenterol 17 2001 72-77.
32. Yang K., Kurihara N., Newmark H., et al. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer Cancer Res 68 2008 7803-7810.
33. Hull MA., Fenwick SW., Chapple KS., et al. Cyclooxygenase-2 expression in colorectal cancer liver metastases Clin Exp Metastasis 18 2000 21-27.
34. Jacoby RF., Seibert K., Cole CE., et al. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis Cancer Res 60 2000 5040-5044.
35. Oshima M., Murai N., Kargman S., et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor Cancer Res 61 2001 1733-1740.
36. Reddy BS., Hirose Y., Lubet R., et al. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis Cancer Res 60 2000 293-297.
37. Myung S., Rerko RM., Yan M., et al. 15-Hydrxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis Proc Nat Acad Sci U S A 103 2006 12098-12102.
38. Janne PA., Mayer RJ Chemoprevention of colorectal cancer N Engl J Med 342 2000 1960-1968.
39. Hawk ET., Umar A., Viner JL Colorectal cancer chemoprevention: an overview of the science Gastroenterology 126 2004 1423-1447.
40. Kelloff GJ., Lippman S., Dannenberg AJ., et al. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward Clin Cancer Res 12 2006 3661-3697.
41. Baron JA., Beach M., Mandel JS., et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group N Engl J Med 340 1999 101-107.
42. Gupta AK., Schoen RE Abberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans? Curr Opin Gastroenterol 25 2009 59-65.
43. Grau M., Baron JA., Sandler RS., et al. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial J Natl Cancer Inst 99 2007 129-136.
44. Grau MV., Baron JA., Sandler RS., et al. Vitamin D, calcium supplementation and coorectal adenomas: results of a randomized trial J Natl Cancer Inst 95 2003 1765-1771.
45. Mizoue T., Kimura Y., Toyomura K., et al. Calcium dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka colorectal cancer study Cancer Epidemol Biomarkers Prev 17 2008 2800-2807.
46. Kim YI., Shirwadkar S., Choi SW., et al. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon Gastroenterology 119 2000 151-161.
47. Cole BF., Baron JA., Sandler RS., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial JAMA 297 2007 2351-2359.
48. Ulrich CM., Potter JD Folate and cancer-timing is everything JAMA 297 2007 2408-2409.
49. Figureido JC., Levine J., Grau M., et al. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels Cancer Epidemiol Biomarkers Prev 17 2008 2625-2631.
50. Logan RF., Grainge MJ., Shepherd VC., et al. Aspirin and folic acid for prevention of recurrent colorectal adenomas Gastroenterology 134 2008 29-38.
51. Chlebowski RT., Wactawski-Wende J., Ritenbaugh., et al. Estrogen plus progestin and colorectal cancer in postmenopausal women N Engl J Med 350 2004 991-1004.
52. Botteri E., Iodice S., Bagnardi V., et al. Smoking and colorectal cancer JAMA 300 2008 2765-2778.
53. Flossman E., Rothwell PM Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomized and observational studies Lancet 369 2007 1603-1613.
54. Sandler RS., Halabi S., Baron JA., et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer N Engl J Med 348 2003 883-890.
55. Baron JA., Cole BF., Sandler RS., et al. A randomized trial of aspirin to prevent colorectal adenomas N Engl J Med 348 2003 891-899.
56. Benamouzig R., Deyra J., Martin A., et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial Gastroenterology 125 2003 328-336.
57. Cruz-Correa M., Hylind LM., Romans KE., et al. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study Gastroenterology 122 2002 641-645.
58. Giardiello FM., Yang VW., Hylind LM., et al. Primary chemoprevention of familial adenomatous polyposis with sulindac N Engl J Med 346 2002 1054-1059.
59. Steinbach G., Lynch PM., Phillips RK., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 2000 1946-1952.
60. Bertagnolli MM., Eagle CJ., Zauber AG., et al. Celecoxib for the prevention of sporadic colorectal adenomas N Engl J Med 355 2006 873-884.
61. Arber N., Eagle CJ., Spicak J., et al. Celecoxib for the prevention of colorectal adenomatous polyps N Engl J Med 355 2006 885-895.
62. Baron JA., Sandler RS., Bresalier RS., et al. A randomized trial of rofecoxib for the prevention of colorectal adenomas Gastroenterology 131 2006 1674-1682.
63. Bresalier RS., Sandler RS., Quan H., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 2005 1092-1102.
64. Meyskins FL., McLaren CE., Pelot D., et al. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial Cancer Prev Res 1 2008 9-11.
65. Poynter JN., Gruber S., Higgins PDR., et al. Statins and the risk of colorectal cancer N Engl J Med 352 2005 2184-2192.
66. Lichtenstein P., Holm NV., Verkasalo PK., et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2000 78-85.
67. Chung DC The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis Gastroenterology 119 2000 854-865.
68. Grady WM Genomic instability and colon cancer Cancer Metastasis Rev 23 2004 11-27.
69. Grady WM., Carethers JM Genomic and epigenetic instability in colorectal cancer pathogenesis Gastroenterology 135 2008 1079-1099.
70. Kahlenberg MS., Stoler DL., Rodriguez-Bigas MA., et al. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma Cancer 88 2000 1814-1819.
71. Waterman ML Lymphoid enhancer factor/T cell factor expression in colorectal cancer Cancer Metastasis Rev 23 2004 41-52.
72. Watanabe T., Wu TT., Catalano PJ., et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl J Med 344 2001 1196-1206.
73. Yoshida BA., Sokoloff MM., Welch DR., Rinker-Schaeffer CW Metastasis-suppressor genes: a review and perspective on an emerging field J Natl Cancer Inst 92 2000 1717-1730.
74. Chung DC., Rustgi AK The hereditary nonpolyposis colorectal cancer NCER syndrome: genetics and clinical implications Ann Intern Med 138 2003 560-570.
75. Gryfe R., Kim H., Hsieh ET., et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2000 69-77.
76. Tajima A., Hess MT., Cabrera BL., et al. The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance Gastroenterology 127 2004 1678-1684.
77. Ribic CM., Sargent DJ., Moore MJ., et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247-257.
78. Rashid A., Issa JP CpG island methylation in gastroenterologic neoplasia: a maturing field Gastroenterology 127 2004 1578-1588.
79. Schetter AJ., Leung SY Sohn JJ., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma JAMA 299 2008 425-436.
80. Byrd JC., Bresalier RS Mucins and mucin binding proteins in colorectal cancer Cancer Metastasis Rev 23 2004 77-99.
81. Zucker S., Vacirca J Role of matrix metalloproteinases (MMPs) in colorectal cancer Cancer Metastasis Rev 23 2004 101-117.
82. Byrd JC., Bresalier RS Galectin-3 in the progression and metastasis of colorectal neoplasia In: Klyosov A., Witczak ZJ., Platt D Galectins 2008 John Wiley and Sons Hoboken, NJ 193-222.
83. Bresalier RS., Byrd JC., Tessler D., et al. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer Gastroenterology 127 2004 741-748.
84. Half EE., Bresalier R Clinical management of hereditary colorectal cancer syndromes Curr Opin Gastroenterol 20 2004 32-42.
85. Rodriguez-Bigas MA., Boland CR., Hamilton SR., et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines J Natl Cancer Inst 89 1997 1758-1762.
86. Will O., Carvajal-Carmona LG., Gornman P., et al. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer Gastroenterology 132 2007 527-530.
87. Burt RW Colon cancer screening Gastroenterology 119 2000 837-853.
88. Daley D., Lewis S., Platzer P., et al. Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study Am J Human Genet 82 2008 723-736.
89. Driver JA., Gasrzian JM., Gelber RP., et al. Development of a risk score for colorectal cancer in men Am J Med 120 2007 257-263.
90. Brenner H., Hoffmeister M., Stegmaier C., et al. Risk of progression of advanced adenomas to colorectal cancer by age, and sex: estimates based on 840, 149 screening colonoscopies Gut 56 2009 1585-1589.
91. Byers T., Nestle M., McTiernan A., et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity CA Cancer J Clin 52 2002 92-119.
92. Smith RA., von Eschenbach AC., Wender R., et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: Update 2001-testing for early lung cancer detection CA Cancer J Clin 51 2001 38-75.
93. Smith RA., Cokkinides V., Eyre HJ American Cancer Society guidelines for the early detection of cancer, 2004 CA Cancer J Clin 54 2004 41-52.
94. Pignone M., Rich M., Teutsch SM., et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 2002 132-141.
95. Bond JH Polyp guideline. Diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 95 2000 3053-3063.
96. Levin B., Lieberman DA., Mcfarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology CA Cancer J Clin 58 2008 130-160.
97. Rex DK., Kahi CJ., Levin B., et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American cancer Society and the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 130 2006 1865-1871.
98. Kahi CJ., Rex DK., Imperiale TF Screening, surveillance and primary prevention for colorectal cancer: a review of the literature Gastroenterology 135 2008 380-399.
99. Giardiello FM., Brensinger JD., Tersmette AC., et al. Very high risk of cancer in familial Peutz-Jeghers syndrome Gastroenterology 119 2000 1447-1453.
100. Carethers JM Hamartomatous polyposis syndromes: genetic pathways Curr Opin Gastroenterol 18 2002 60-67.
101. Van Hattem WA., Brosens LAA., De Leng WWJ Large genomic deletions of SMA4, BMPR1A and PTEN in juvenile polyposis Gut 57 2008 623-627.
102. Brosens LAA., Van Hattem A., Hylind LM., et al. Risk of colorectal cancer in juvenile polyposis Gut 56 2007 965-967.
103. Eaden JA., Abrams KR., Mayberry JF The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 48 2001 526-535.
104. Heuschen UA., Henz U., Allemeyer EH., et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis Gastroenterology 120 2001 841-847.
105. Friedman S., Rubin PH., Bodian C., et al. Screening and surveillance colonoscopy in chronic Crohn’s colitis Gastroenterology 120 2001 820-826.
106. Lagergren J., Ye W., Ekbom A Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology 121 2001 542-547.
107. Jones S., Chen W., Parmigiani G., et al. Comparative lesion sequencing provides insights into tumor evolution PNAS 105 2008 4283-4288.
108. American Joint Committee on Cancer AJCC cancer staging manual: colon and rectum6th ed 2002 Springer-Verlag New York p 113.
109. Prorok PC., Andriole GL., Bresalier RS., et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Control Clin Trials 21 suppl 6 2000 273S-309S.
110. Winawer SJ., Stewart ET., Zauber AG., et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group N Engl J Med 342 2000 1766-1772.
111. U.S. Preventative Services Task Force Screening for colorectal cancer: U.S. Preventative Services Task Force recommendation statement Ann Int Med 149 2008 627-637.
112. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence Gastroenterology 124 2003 544-560.
113. Hardcastle JD., Chamberlain JO., Robinson MH., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472-1477.
114. Mandel JS., Bond JH., Church TR., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 1993 1365-1371.
115. Zauber A., Landsdorp-Vogelaar I., Knudsen AB., et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventative Services task Force Ann Int Med 149 2008 659-669.
116. Sonnenberg A., Delco F., Inadomi JM Cost-effectiveness of colonoscopy in screening for colorectal cancer Ann Intern Med 133 2000 573-584.
117. Inadomi JM Update on cost-effectiveness of screening for colorectal neoplasia Curr Opin Gastroenterol 19 2003 44-50.
118. Pignone M., Saha S., Hoerger T., Mandelblatt J Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 137 2002 96-104.
119. U.S. Preventive Services Task Force Screening for colorectal cancer: Recommendation and rationale Ann Intern Med 137 2002 129-131.
120. Collins JF., Lieberman DA., Durbin TE., et al. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination Ann Intern Med 142 2005 81-85.
121. Mandel JS., Church TR., Ederer F., Bond JH Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood J Natl Cancer Inst 91 1999 434-437.
122. Faivre J., Dancourt V., Lejeune C., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French-controlled study Gastroenterology 126 2004 1674-1680.
123. Levi Z., Rozen P., Hazazi R., et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia Ann Int Med 146 2007 244-255.
124. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 2009 210-214.
125. Selby JV., Friedman GD., Quesenberry CP Jr., Weiss NS A case-control study of screening sigmoidoscopy and mortality from colorectal cancer N Engl J Med 326 1992 653-657.
126. Atkin W., Rogers P., Cardwell C., et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy Gastroenterology 126 2004 1247-1256.
127. Schoen RE., Pinsky PF., Weissfeld JL., et al. Results of repeat sigmoidoscopy 3 years after a negative examination JAMA 290 2003 41-48.
128. Winawer SJ., Zauber AG., Ho MN., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 1993 1977-1981.
129. Lakoff J., Paszat LF., Saskin R., Rabeneck L Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population based study Clin Gastroenterol Hepatol 6 2008 1117-1121.
130. Baxter NN., Goldwasser MA., Paszat LF., et al. Association of colonoscopy and death from colorectal cancer Ann Int Med 150 2009 1-8.
131. Imperiale TF., Wagner DR., Lin CY., et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings N Engl J Med 343 2000 169-174.
132. Lieberman DA., Weiss DG., Bond JH., et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380 N Engl J Med 343 2000 162-168.
133. Soetikno RM., Kaltenbach T., Rouse RV., et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults JAMA 299 2008 1027-1035.
134. Toma J., Paszat LF., Gunraj N., Rabeneck L Rates of new or missed colorectal cancer after barium enema and their risk factors: a population-based study Am J Gastroenterol 103 2008 3149-3151.
135. Iannaccone R., Laghi A., Catalano C., et al. Computed tomographic colonography without cathartic preparation for the detection of colorectal polyps Gastroenterology 127 2004 1300-1311.
136. Chaoui A., Barish MA Virtual colonoscopy: a new tool for colorectal cancer screening Curr Opin Gastroenterol 17 2001 78-85.
137. Johnson CD., Harmsen WS., Wilson LA., et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps Gastroenterology 125 2003 311-319.
138. Pineau BC., Paskett ED., Chen GJ., et al. Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps Gastroenterology 125 2003 304-310.
139. Pickhardt PJ., Choi JR., Hwang I., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults N Engl J Med 349 2003 2191-2200.
140. Cotton PB., Durkalski VL., Pineau BC., et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia JAMA 291 2004 1713-1719.
141. Johnson DJ., Chen M-H., Toledano AY., et al. Accuracy of CT colonography for detection of large adenomas and cancer N Engl J Med 359 2008 1207-1217.
142. Kim D., Pickhardt PJ., Taylor AJ., et al. CT colonography versus colonoscopy for the detection of advanced neoplasia N Engl J Med 357 2007 1403-1412.
143. Pickhardt PJ., Nugent PA., Mysliwiec PA., et al. Location of adenomas missed by optical colonoscopy Ann Intern Med 141 2004 352-359.
144. Ransohoff DF Cancer: developing molecular biomarkers for cancer Science 299 2003 1679-1680.
145. Ahlquist DA., Skoletsky JE., Boynton KA., et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel Gastroenterology 119 2000 1219-1227.
146. Imperiale TF., Ransohoff DF., Itzkowitz SH., et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population N Engl J Med 351 2004 2704-2714.
147. Ahlquist DA., Sargent DJ., Loprinzi CL., et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia Ann Int Med 149 2008 441-450.
148. Stern HS., Viertelhausen S., Hunter AG., et al. APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews Gastroenterology 120 2001 392-400.
149. Jarvinen HJ., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer Gastroenterology 118 2000 829-834.
150. Lieberman DA., Weiss DG., Harford WV., et al. Five year colon surveillance after screening colonoscopy Gastroenterology 133 2007 1077-1085.
151. Laiyermo AO., Murphy G., Albert PS., et al. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenomas at 4 years Ann Int Med 148 2008 419-426.
152. Gross CP., Anderson MS., Krumholtz HM., et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer JAMA 296 2006 2815-2822.
153. Seeff LC., Richards TB., Shapiro JA., et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity Gastroenterology 127 2004 1670-1677.
154. Seeff LC., Manninen DL., Dong FB., et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the U.S.? Gastroenterology 127 2004 1661-1669.
155. Mysliwiec PA., Brown ML., Klabunde CN., Ransohoff DF Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy Ann Intern Med 141 2004 264-271.
156. Imperiale TF., Wagner DR., Lin CY., et al. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer Ann Intern Med 139 2003 959-965.
157. Song K., Fendrick AM., Ladabaum U Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis Gastroenterology 126 2004 1270-1279.
158. Lieberman DA., Holub JL., Moravrc MD., et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients JAMA 300 2008 1417-1422.
159. Murff HJ., Peterson NB., Fowke JH., et al. Colonoscopy screening in African Americans and whites with affected first degree relatives Arch Int Med 168 2008 625-631.
160. Chen LA., Santos S., Jadof L., et al. A program to enhance completion of screening colonoscopy among urban minorities Clin Gastroenterol Hepatol 6 2008 443-450.
161. Barclay RL., Vicari JJ., Greenlaw RL Effect of a time dependent colonoscopic withdrawal protocol on adenoma detection during colonoscopy Gastroenterology 6 2008 1091-1098.
162. Chang GJ., Rodriguez-Bigas MA., Skibber JM., Moyer VA Lymph node evaluation and survival after curative resection of colon cancer: a systematic review J Natl Cancer Inst 99 2007 433-441.
163. Curley SA., Izzo F., Abdalla E., Vauthey JN Surgical treatment of colorectal cancer metastasis Cancer Metastasis Rev 23 2004 165-182.
164. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology. Colon Cancer, V.3.2009. www.NCCN.ORG.
165. Pfister DG., Benson AB III., Somerfield MR Clinical practice: surveillance strategies after curative treatment of colorectal cancer N Engl J Med 350 2004 2375-2382.
166. Covey AM., Brown KT., Jarnagin WR., et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for respectable hepatic colorectal metastases Ann Surg 247 2008 451-455.
167. Allegra C., Sargent DJ Adjuvant therapy for colon cancer-the pace quickens N Engl J Med 352 2005 2746-2748.
168. International Multicenter Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators Efficacy of adjuvant fluorouracil, leucovorin, and levamisole in Dukes B and C carcinoma of the colon: results of the National Adjuvant Breast and Bowel Project C-04 Lancet 345 2000 939-944.
169. Twelves C., Wong A., Nowacki MP., et al. Capcitabine as adjuvant treatment for stage III colon cancer N Engl; J Med 352 2005 2696-2704.
170. Andre T., Boni C., Mounedji-Boudiaf L., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343-2351.
171. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology. Colon Cancer http://www.nccn.org/professionals/physician_gls/f_guidelines.asp 2008 [Internet] [cited 2009 Jun 23] Available at.
172. Quasar Collaborative Group Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomized study Lancet 370 2007 2020-2029.
173. Gill S., Loprinzi CL., Sargent DJ., et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22 2004 1797-1806.
174. Ajlouni M The role of radiation in adjuvant treatment of rectal cancer Curr Opin Gastroenterol 17 2001 86-90.
175. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731-1740.
176. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology. Rectal cancer http://www.nccn.org/professionals/physician_gls/f_guidelines.asp 2008 [Internet] [cited 2009 Jun 23] Available at.
177. Piedbois P., Michaels S., for the Meta-analysis Group in Cancer Survival benefit of 5FU/LV over 5FU bolus in patients with advanced colorectal cancer: an updated meta-analysis based on 2, 751 patients Proc Am Assoc Cancer Res Proc Am Soc Clin Oncol 22 2003 abstr 1180.
178. Goldberg RM., Sargent DJ., Morton RF., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 2004 23-30.
179. Hoff PM., Ansari R., Batist G., et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study J Clin Oncol 19 2001 2282-2292.
180. Saltz LB., Cox JV., Blanke C., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med 343 2000 905-914.
181. Douillard JY., Cunningham D., Roth AD., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 2000 1041-1047.
182. Karpetis CS., Khambata-Ford S., Jonker DK., et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer N Engl J Med 359 2008 1757-1765.
183. Mocellin S., Rossi CR., Lise M., Nitti D Colorectal cancer vaccines: principles, results, and perspectives Gastroenterology 127 2004 1821-1837.
184. O’Connell MJ., Martenson JA., Wiand HS., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 1994 502-507.
185. Kimmey MB Endoscopic methods (other than stents) for palliation of rectal carcinoma J Gastrointest Surg 8 2004 270-273.
186. Dekovich A Endoscopic treatment of colonic obstruction Current Opin Gastroenterol 25 2009 50-54.